In addition, the text covers efforts towards drug development in infectious diseases from academic groups and non profit organizations.
Preamble Editor Preface PART I Drug Discovery Approaches 1 Target identification and mechanism-based screening for anthelmintics: Application of veterinary antiparasitic research programmes to search for new antiparasitic drugs for human indications 2 Anthelmintic resistance as a guide to the discovery of new drugs? Selzer studied Biology, Parasitology, and Biochemistry at the University of Tbingen, Germany, where he also received his Ph D in Biochemistry on subjects related to the protozoan parasite Trypanosoma brucei.
If this is a republication request please include details of the new work in which the Wiley content will appear.
In this article, challenges and opportunities for antiparasitic drug discovery are considered, highlighting some of the progress that has been made in recent years, partly through scientific advances, but also by more effective partnership between the public and private sectors.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Malaria Control & Elimination Malaria is a global health problem that causes significant mortality and morbidity annually and a serious problem to drug therapy and discovery as current anti-malarial therapeutics become increasingly ineffective.
The need for new therapy for malaria is mandatory because of the emergence of resistance to most of the anti-malarial drugs.
There are different approaches and targets proposed by researchers and scientist based on experimental data.